Abstract: A cerium manganese catalyst for ozone decomposition, which is mainly a composite oxide of Mn2O3 and CeO2 with the chemical constitution of CeMnaOx, a being a natural number selected from 6 to 15. A method for preparing a catalyst comprises: mixing a solution containing a cerium source and a manganese source with excessive urea, reacting to obtain a precipitate, washing the precipitate to neutral, drying, and roasting to obtain the cerium manganese catalyst.

Abstract: A drug delivery system includes a packaging housing a first component including at least one of a drug product, a diluent, a saline solution, or an IV stabilizing solution (“IVSS”) and a second component comprising at least one of the drug product, the diluent, the saline solution, and the IVSS, the first component being different than the second component. The first component is disposed in a first container in a storage state and the first container is positioned in a first compartment of the packaging housing. The second component is disposed in a second container in a storage state and the second container is positioned in a second compartment of the packaging housing. At least one of the first compartment and the second compartment may include an individual seal and wherein each of the individual seals and the first and second compartments are sterilized.

Abstract: Drug reconstitution systems and related methods are disclosed herein. A drug reconstitution system may include a first component in a first container in a storage state and a second component in a second container in a storage state. The first component may be selected from a group of a drug product, a diluent, a saline solution, and an IV stabilizing solution (“IVSS”). The second component may be selected from a group of the drug product, the diluent, the saline solution, and the IVSS. The first component may be different than the second component. At least one fluid path may be configured to at least selectively fluidly connect the first container and the second container. An urging assembly may be configured to selectively urge at least a portion of the first component from the first container and into contact with the second component.

Abstract: A method for information processing and an electronic device are provided. At a server, a first vehicle-exchange request of a first user is received from a first electronic device, where the first vehicle-exchange request includes first exchange-target-vehicle-type-information. A second vehicle-exchange request of a second user is received at the server from a second electronic device, where the second vehicle-exchange request includes second exchange-target-vehicle-type-information. When a first vehicle of the first user matches the second exchange-target-vehicle-type-information, and a second vehicle of the second user matches the first exchange-target-vehicle-type-information, information of the second user and the second vehicle is transmitted to the first electronic device, and information of the first user and the first vehicle is transmitted to the second electronic device.

Abstract: A method and device for constructing object motion trajectory, and a computer readable storage medium are provided. The method for constructing object motion trajectory includes that: at least two different types of object features matching with a search condition are acquired, the at least two different types of object features including at least two of face features, body features or vehicle features; photographing time points and photographing places that are respectively associated with the at least two different types of object features are acquired; and an object motion trajectory is generated according to a combination of the photographing time points and the photographing places that are respectively associated with the at least two different types of object features.

Abstract: A method for behavior analysis includes: obtaining the profile information of a target object, where the profile information includes personal information of the target object, at least one captured image of the target object and image capturing information of the captured image, where the image capturing information includes a capture location; obtaining information of one or more Points of Interest (POIs) of a surrounding area of the capture location based on map data, where the surrounding area represents a preset geographic area including the capture location; and obtaining behavior data of the target object based on the information of the POIs and the profile information of the target object.

Abstract: An information processing method and apparatus, and a storage medium, the method including: on the basis of aggregated archive data, determining a target object; acquiring first capture image information of the target object; analysing the first capture information to obtain a first analysis result; and, on the basis of the first analysis result, determining a first trajectory of the target object.

Abstract: A cerium manganese catalyst for ozone decomposition, which is mainly a composite oxide of Mn2O3 and CeO2 with the chemical constitution of CeMnaOx, a being a natural number selected from 6 to 15. A method for preparing a catalyst comprises: mixing a solution containing a cerium source and a manganese source with excessive urea, reacting to obtain a precipitate, washing the precipitate to neutral, drying, and roasting to obtain the cerium manganese catalyst.

Abstract: The present invention relates to a cutter replacement robot and its adaptive cutter system for tunnel boring machine and belongs to the field of tunnel construction equipment design. Traditional cutter system adopts multi-wedge fastening mode, and the fasteners are many and separate from each other. It is only suitable for manual disassembly and assembly. So, robot can not disassemble and assemble cutter quickly. For the current cutter weight, the current load-weight ratio of industrial robots can not meet the narrow space inside the cutter head of the TBM, so mature industrial robots can not change the all of cutters. Based on the above situation, according to the internal space structure of the cutter head of the TBM, the invention designs a new type of cutter-changing robot and three type cutter systems to realize the rapid disassembly and assembly of the cutter.

Abstract: AXOR35 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing AXOR35 polypeptides and polynucleotides in diagnostic assays.

Abstract: RB204 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing RB204 polypeptides and polynucleotides in diagnostic assays.

Abstract: AXOR35 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing AXOR35 polypeptides and polynucleotides in diagnostic assays.

Abstract: PDF polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing PDF polypeptides and polynucleotides in diagnostic assays.

Abstract: The MT-MMP5-L polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing MT-MMP5-L polypeptides and polynucleotides in therapy, and diagnostic assays for such.

Abstract: HC/BTLP polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing hC/BTLP polypeptides and polynucleotides in the design of protocols for the treatment of restenosis, atherosclerosis, congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), benign prostatic hypertrophy (BPH), nephritis, fibrosis, glomerulonephritis, gliosis, cirrhosis and anomalies of wound healing, such as keloids among others, and diagnostic assays for such conditions.

Abstract: mASP-2 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for screening for compounds that either agonize or antagonize mASP-2. Such compounds are expected to be useful in treatment of human diseases, including, but not limited to: Alzheimer's disease, cancer and prohormone processing.

Abstract: Mouse mASP1 polypeptides and polynucleotides and method for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for screening for compounds that either agonize or antagonize mouse mASP1. Such compounds are expected to be useful in treatment of human diseases, including, but not limited to: Alzheimer's disease, cancer, and prohormone processing.

Abstract: FHAR1 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing FHAR1 polypeptides and polynucleotides in diagnostic assays.

Abstract: Human H218 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing Human H218 polypeptides and polynucleotides in therapy, and diagnostic assays for such.

Abstract: Paul polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing Paul polypeptides and polynucleotides in diagnostic assays.